COPD and air travel oxygen equipment and preflight titration of supplemental oxygen

Chest

Volumn 140, Issue 1, 2011, Pages 84-90

  Akerø, Aina ^a   Edvardsen, Anne ^c   Christensen, Carl C ^b   Owe, Jan O ^b   Ryg, Morten ^c   Skjønsberg, Ole H ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Institute of Aviation Medicine   (Norway)

^c Glittreklinikken ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADULT; ARTICLE; AVIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FLIGHT; HUMAN; HYPOXIA; HYPOXIA ALTITUDE SIMULATION TEST; LUNG FUNCTION TEST; MALE; MEDICAL INSTRUMENTATION; NASOGASTRIC TUBE; OXYGEN TENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 79960434325     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0965     Document Type: Article

References (30)

1. British Thoracic Society Standards of Care Committee. Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax. 2002;57(4):289-304.
2. Aerospace Medical Association Medical Guidelines Task Force. Medical guidelines for airline travel, 2nd ed. Aviat Space Environ Med. 2003;74(5)(Suppl):A1-A19.
3. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152(5 Pt 2):S77-S121.
4. Lien D, Turner M. Recommendations for patients with chronic respiratory disease considering air travel: a statement from the Canadian Thoracic Society. Can Respir J. 1998;5(2):95-100. (Pubitemid 28230228)
5. Siafakas NM, Vermeire P, Pride NB, et al; The European Respiratory Society Task Force. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J. 1995;8(8):1398-1420.
6. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932-946. (Pubitemid 38807371)
7. Akerø A, Christensen CC, Edvardsen A, Ryg M, Skjønsberg OH. Pulse oximetry in the preflight evaluation of patients with chronic obstructive pulmonary disease. Aviat Space Environ Med. 2008;79(5):518-524. (Pubitemid 351619958)
8. Coker RK, Shiner RJ, Partridge MR. Is air travel safe for those with lung disease? Eur Respir J. 2007;30(6):1057-1063. (Pubitemid 351194750)
9. Naughton MT, Rochford PD, Pretto JJ, Pierce RJ, Cain NF, Irving LB. Is normobaric simulation of hypobaric hypoxia accurate in chronic airflow limitation? Am J Respir Crit Care Med. 1995;152(6 Pt 1):1956-1960.
10. Dillard TA, Moores LK, Bilello KL, Phillips YY. The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure. Chest. 1995;107(2):352-357.
11. Mohr LC. The hypoxia altitude simulation test: an increasingly performed test for the evaluation of patients prior to air travel. Chest. 2008;133(4):839-842. (Pubitemid 351536855)
12. Kelly PT, Swanney MP, Stanton JD, Frampton C, Peters MJ, Beckert LE. Supplemental oxygen effect on hypoxemia at moderate altitude in patients with COPD. Aviat Space Environ Med. 2009;80(9):815-819.
13. Cramer D, Ward S, Geddes D. Assessment of oxygen supplementation during air travel. Thorax. 1996;51(2):202-203. (Pubitemid 26058158)
14. Berg BW, Dillard TA, Rajagopal KR, Mehm WJ. Oxygen supplementation during air travel in patients with chronic obstructive lung disease. Chest. 1992;101(3):638-641.
15. Vohra KP, Klocke RA. Detection and correction of hypoxemia associated with air travel. Am Rev Respir Dis. 1993;148(5):1215-1219. (Pubitemid 23326016)
16. Dine CJ, Kreider ME. Hypoxia altitude simulation test. Chest. 2008;133(4):1002-1005. (Pubitemid 351536879)
17. Mohr LC. Hypoxia during air travel in adults with pulmonary disease. Am J Med Sci. 2008;335(1):71-79.
18. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16 : 5-40.
19. Gong H Jr, Tashkin DP, Lee EY, Simmons MS. Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction. Am Rev Respir Dis. 1984;130(6):980-986. (Pubitemid 15191905)
20. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-381. (Pubitemid 13215050)
21. Federal Aviation Administration. Special Federal Aviation Regulation 106. Rules for use of additional portable oxygen concentrator devices on board aircaft. 14 CFR §121 (2010).
22. Code of Federal Regulations. Title 14 CFR, Part 25.841. Washington, DC: US Government Printing Office; 1986.
23. Akerø A, Christensen CC, Edvardsen A, Skjønsberg OH. Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight. Eur Respir J. 2005;25(4):725-730. (Pubitemid 40528769)
24. Edvardsen A, Akerø A, Hardie JA, et al. High prevalence of respiratory symptoms during air travel in patients with COPD. Respir Med. 2011;105(1):50-56.
25. Kelly PT, Swanney MP, Seccombe LM, Frampton C, Peters MJ, Beckert L. Air travel hypoxemia vs. the hypoxia inhalation test in passengers with COPD. Chest. 2008;133(4):920-926. (Pubitemid 351536867)
26. Robson AG, Lenney J, Innes JA. Using laboratory measurements to predict in-flight desaturation in respiratory patients: are current guidelines appropriate? Respir Med. 2008;102(11):1592-1597.
27. Dunne PJ. The clinical impact of new long-term oxygen therapy technology. Respir Care. 2009;54(8):1100-1111.
28. Dillard TA, Bansal AK. Commentary: pulse oximetry during airline travel. Aviat Space Environ Med. 2007;78(2):143-144. (Pubitemid 46213114)
29. Mehm WJ, Dillard TA, Berg BW, Dooley JW, Rajagopal KR. Accuracy of oxyhemoglobin saturation monitors during simulated altitude exposure of men with chronic obstructive pulmonary disease. Aviat Space Environ Med. 1991;62(5):418-421.
30. Christensen CC, Ryg M, Refvem OK, Skjønsberg OH. Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude. Eur Respir J. 2000;15(4):635-639. (Pubitemid 30196288)